Verseon Corp Company Profile (LON:VSN)

About Verseon Corp (LON:VSN)

Verseon Corp logoVerseon Corporation is a pharmaceutical company. The Company's platform models interactions between a protein and a drug molecule with precision sufficient for designing drug candidates. The Company operates through the pharmaceutical research segment. The Company uses its drug discovery technology to develop a portfolio of programs targeting disease areas consisting of anti-coagulation, diabetic macular edema (DMA) and oncology. The Company's platform generates a range of drug-like, synthesizable compounds, which are then computationally tested against a disease-causing protein to identify the binders, the drug candidates that could potentially treat the disease. These computationally designed candidates are synthesized and sent through a series of disease specific in vitro and in vivo tests to identify the candidates for clinical testing in humans.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology & Medical Research - NEC
  • Sub-Industry: N/A
  • Symbol: LON:VSN
  • CUSIP: N/A
  • Web: www.verseon.com/
Capitalization:
  • Market Cap: £221.82 million
  • Outstanding Shares: 151,414,000
Average Prices:
  • 50 Day Moving Avg: GBX 146.85
  • 200 Day Moving Avg: GBX 154.33
  • 52 Week Range: GBX 140 - GBX 166.90
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: N/A
  • Price / Sales: N/A
  • Book Value: GBX 0.40 per share
  • Price / Book: 3.66
Profitability:
  • EBIDTA: ($17,040,000.00)
  • Return on Equity: -3.57%
  • Return on Assets: -2.33%
Misc:
  • Average Volume: 54,648 shs.
 
Frequently Asked Questions for Verseon Corp (LON:VSN)

What is Verseon Corp's stock symbol?

Verseon Corp trades on the London Stock Exchange (LON) under the ticker symbol "VSN."

When will Verseon Corp make its next earnings announcement?

Verseon Corp is scheduled to release their next quarterly earnings announcement on Tuesday, September, 5th 2017. View Earnings Estimates for Verseon Corp.

Who are some of Verseon Corp's key competitors?

Who are Verseon Corp's key executives?

Verseon Corp's management team includes the folowing people:

  • Adityo Prakash, Chief Executive Officer, Founder, Executive Director
  • Eniko Fodor, Founder, Chief Financial Officer, Chief Operating Officer, Executive Director
  • David Kita, Founder, Vice President - Research & Development
  • Anirban Datta, Director - Discovery Biology
  • Kevin Short, Director - Discovery Programs
  • David Williams, Director - R&D
  • Thomas A Hecht, Non-Executive Chairman of the Board
  • Alastair Andrew Bertram Cade, Non-Executive Director
  • Grover T. Wickersham, Non-Executive Director

How do I buy Verseon Corp stock?

Shares of Verseon Corp and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Verseon Corp's stock price today?

One share of Verseon Corp stock can currently be purchased for approximately GBX 146.50.


MarketBeat Community Rating for Verseon Corp (LON VSN)
Community Ranking:  3.7 out of 5 (  )
Outperform Votes:  17 (Vote Outperform)
Underperform Votes:  6 (Vote Underperform)
Total Votes:  23
MarketBeat's community ratings are surveys of what our community members think about Verseon Corp and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Verseon Corp (LON:VSN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: N/A

Analysts' Ratings History for Verseon Corp (LON:VSN)
Show:
DateFirmActionRatingPrice TargetDetails
7/4/2017Cenkos Securities LtdReiterated RatingBuyView Rating Details
(Data available from 7/25/2015 forward)

Earnings

Earnings History for Verseon Corp (LON:VSN)
Earnings by Quarter for Verseon Corp (LON:VSN)
Earnings History by Quarter for Verseon Corp (LON VSN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
9/5/2017N/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Verseon Corp (LON:VSN)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Verseon Corp (LON:VSN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Verseon Corp (LON:VSN)
Insider Trades by Quarter for Verseon Corp (LON:VSN)
Insider Trades by Quarter for Verseon Corp (LON:VSN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/21/2016Fodor,EnikoInsiderBuy6,000GBX 161£9,660
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Verseon Corp (LON:VSN)
Latest Headlines for Verseon Corp (LON:VSN)
Source:

Social

Social activity is not available for this stock.

Chart

Verseon Corp (VSN) Chart for Tuesday, July, 25, 2017

This page was last updated on 7/25/2017 by MarketBeat.com Staff